The pediatric liver transplant program at the Universite Catholique de Louvain, Cliniques Saint-Luc, Brussels: Overall results in 444 children (1984-1997)

R. Reding, F. Gennari, M. Janssen, J. Jamart, J. De Ville de Goyet, J. Lerut, E. Sokal, J. B. Otte

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Between 1984 and 1997, a total of 444 children (<15 years) received an orthotopic liver transplant (OLT) at Saint-Luc University Clinics. Biliary atresia constituted the indication for OLT in 304 cases (68%). Median age (range) at OLT was 2.1 years (0.3-14.5). 177 children (40%) received a whole liver graft, 184 (41%) a reduced-size graft, 26 (6%) a split liver graft, whereas a living-related donor graft was used in 57 children (13%). Most grafts were ABO-identical or -compatible, in 395 cases (89%) and 40 (9%), respectively. Overall actuarial patient survivals at one and five years were 85% and 81%. The overall retransplantation rate was 19%. The results of uni- and multivariate statistical analyses showed a significant impact of year of transplantation (learning curve effect), with a 15% improvement of patient survival between the 1984-7 and the 1995-7 periods (p <0.002). Results differed according to the indications for OLT, the best survivals being recorded for familial cholestasis, the worst for liver tumor (p = 0.004). Five year patient survival was significantly better after elective OLT (82%), when compared to highly urgent OLT (63%) (p <0.001). Patient survivals were comparable in the children receiving primary cyclosporin-A microemulsion or tacrolimus immunosuppression, which were significantly higher than in the historical group treated with cyclosporin-A. No impact of the age at OLT, type of graft and ischemic time could be reported. In conclusion, this series illustrates the progressive improvements introduced in our pediatric liver transplant program between 1984 and 1997, including the technical variants allowing pediatric OLT using adult donors as well as the introduction of new immunosuppressive strategies.

Original languageEnglish
Pages (from-to)285-289
Number of pages5
JournalActa Gastro-Enterologica Belgica
Volume62
Issue number3
Publication statusPublished - 1999

Fingerprint

Saints
Pediatrics
Transplants
Liver
Survival
Cyclosporine
Biliary Atresia
Learning Curve
Living Donors
Cholestasis
Tacrolimus
Immunosuppressive Agents
Immunosuppression

Keywords

  • Liver transplantation
  • Pediatrics
  • Risk factors
  • Survival analysis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Reding, R., Gennari, F., Janssen, M., Jamart, J., De Ville de Goyet, J., Lerut, J., ... Otte, J. B. (1999). The pediatric liver transplant program at the Universite Catholique de Louvain, Cliniques Saint-Luc, Brussels: Overall results in 444 children (1984-1997). Acta Gastro-Enterologica Belgica, 62(3), 285-289.

The pediatric liver transplant program at the Universite Catholique de Louvain, Cliniques Saint-Luc, Brussels : Overall results in 444 children (1984-1997). / Reding, R.; Gennari, F.; Janssen, M.; Jamart, J.; De Ville de Goyet, J.; Lerut, J.; Sokal, E.; Otte, J. B.

In: Acta Gastro-Enterologica Belgica, Vol. 62, No. 3, 1999, p. 285-289.

Research output: Contribution to journalArticle

Reding, R, Gennari, F, Janssen, M, Jamart, J, De Ville de Goyet, J, Lerut, J, Sokal, E & Otte, JB 1999, 'The pediatric liver transplant program at the Universite Catholique de Louvain, Cliniques Saint-Luc, Brussels: Overall results in 444 children (1984-1997)', Acta Gastro-Enterologica Belgica, vol. 62, no. 3, pp. 285-289.
Reding, R. ; Gennari, F. ; Janssen, M. ; Jamart, J. ; De Ville de Goyet, J. ; Lerut, J. ; Sokal, E. ; Otte, J. B. / The pediatric liver transplant program at the Universite Catholique de Louvain, Cliniques Saint-Luc, Brussels : Overall results in 444 children (1984-1997). In: Acta Gastro-Enterologica Belgica. 1999 ; Vol. 62, No. 3. pp. 285-289.
@article{752f72eaf9f74127bb187daad35cf695,
title = "The pediatric liver transplant program at the Universite Catholique de Louvain, Cliniques Saint-Luc, Brussels: Overall results in 444 children (1984-1997)",
abstract = "Between 1984 and 1997, a total of 444 children (<15 years) received an orthotopic liver transplant (OLT) at Saint-Luc University Clinics. Biliary atresia constituted the indication for OLT in 304 cases (68{\%}). Median age (range) at OLT was 2.1 years (0.3-14.5). 177 children (40{\%}) received a whole liver graft, 184 (41{\%}) a reduced-size graft, 26 (6{\%}) a split liver graft, whereas a living-related donor graft was used in 57 children (13{\%}). Most grafts were ABO-identical or -compatible, in 395 cases (89{\%}) and 40 (9{\%}), respectively. Overall actuarial patient survivals at one and five years were 85{\%} and 81{\%}. The overall retransplantation rate was 19{\%}. The results of uni- and multivariate statistical analyses showed a significant impact of year of transplantation (learning curve effect), with a 15{\%} improvement of patient survival between the 1984-7 and the 1995-7 periods (p <0.002). Results differed according to the indications for OLT, the best survivals being recorded for familial cholestasis, the worst for liver tumor (p = 0.004). Five year patient survival was significantly better after elective OLT (82{\%}), when compared to highly urgent OLT (63{\%}) (p <0.001). Patient survivals were comparable in the children receiving primary cyclosporin-A microemulsion or tacrolimus immunosuppression, which were significantly higher than in the historical group treated with cyclosporin-A. No impact of the age at OLT, type of graft and ischemic time could be reported. In conclusion, this series illustrates the progressive improvements introduced in our pediatric liver transplant program between 1984 and 1997, including the technical variants allowing pediatric OLT using adult donors as well as the introduction of new immunosuppressive strategies.",
keywords = "Liver transplantation, Pediatrics, Risk factors, Survival analysis",
author = "R. Reding and F. Gennari and M. Janssen and J. Jamart and {De Ville de Goyet}, J. and J. Lerut and E. Sokal and Otte, {J. B.}",
year = "1999",
language = "English",
volume = "62",
pages = "285--289",
journal = "Acta Gastro-Enterologica Belgica",
issn = "0001-5644",
publisher = "Universa Press",
number = "3",

}

TY - JOUR

T1 - The pediatric liver transplant program at the Universite Catholique de Louvain, Cliniques Saint-Luc, Brussels

T2 - Overall results in 444 children (1984-1997)

AU - Reding, R.

AU - Gennari, F.

AU - Janssen, M.

AU - Jamart, J.

AU - De Ville de Goyet, J.

AU - Lerut, J.

AU - Sokal, E.

AU - Otte, J. B.

PY - 1999

Y1 - 1999

N2 - Between 1984 and 1997, a total of 444 children (<15 years) received an orthotopic liver transplant (OLT) at Saint-Luc University Clinics. Biliary atresia constituted the indication for OLT in 304 cases (68%). Median age (range) at OLT was 2.1 years (0.3-14.5). 177 children (40%) received a whole liver graft, 184 (41%) a reduced-size graft, 26 (6%) a split liver graft, whereas a living-related donor graft was used in 57 children (13%). Most grafts were ABO-identical or -compatible, in 395 cases (89%) and 40 (9%), respectively. Overall actuarial patient survivals at one and five years were 85% and 81%. The overall retransplantation rate was 19%. The results of uni- and multivariate statistical analyses showed a significant impact of year of transplantation (learning curve effect), with a 15% improvement of patient survival between the 1984-7 and the 1995-7 periods (p <0.002). Results differed according to the indications for OLT, the best survivals being recorded for familial cholestasis, the worst for liver tumor (p = 0.004). Five year patient survival was significantly better after elective OLT (82%), when compared to highly urgent OLT (63%) (p <0.001). Patient survivals were comparable in the children receiving primary cyclosporin-A microemulsion or tacrolimus immunosuppression, which were significantly higher than in the historical group treated with cyclosporin-A. No impact of the age at OLT, type of graft and ischemic time could be reported. In conclusion, this series illustrates the progressive improvements introduced in our pediatric liver transplant program between 1984 and 1997, including the technical variants allowing pediatric OLT using adult donors as well as the introduction of new immunosuppressive strategies.

AB - Between 1984 and 1997, a total of 444 children (<15 years) received an orthotopic liver transplant (OLT) at Saint-Luc University Clinics. Biliary atresia constituted the indication for OLT in 304 cases (68%). Median age (range) at OLT was 2.1 years (0.3-14.5). 177 children (40%) received a whole liver graft, 184 (41%) a reduced-size graft, 26 (6%) a split liver graft, whereas a living-related donor graft was used in 57 children (13%). Most grafts were ABO-identical or -compatible, in 395 cases (89%) and 40 (9%), respectively. Overall actuarial patient survivals at one and five years were 85% and 81%. The overall retransplantation rate was 19%. The results of uni- and multivariate statistical analyses showed a significant impact of year of transplantation (learning curve effect), with a 15% improvement of patient survival between the 1984-7 and the 1995-7 periods (p <0.002). Results differed according to the indications for OLT, the best survivals being recorded for familial cholestasis, the worst for liver tumor (p = 0.004). Five year patient survival was significantly better after elective OLT (82%), when compared to highly urgent OLT (63%) (p <0.001). Patient survivals were comparable in the children receiving primary cyclosporin-A microemulsion or tacrolimus immunosuppression, which were significantly higher than in the historical group treated with cyclosporin-A. No impact of the age at OLT, type of graft and ischemic time could be reported. In conclusion, this series illustrates the progressive improvements introduced in our pediatric liver transplant program between 1984 and 1997, including the technical variants allowing pediatric OLT using adult donors as well as the introduction of new immunosuppressive strategies.

KW - Liver transplantation

KW - Pediatrics

KW - Risk factors

KW - Survival analysis

UR - http://www.scopus.com/inward/record.url?scp=0032872825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032872825&partnerID=8YFLogxK

M3 - Article

C2 - 10547893

AN - SCOPUS:0032872825

VL - 62

SP - 285

EP - 289

JO - Acta Gastro-Enterologica Belgica

JF - Acta Gastro-Enterologica Belgica

SN - 0001-5644

IS - 3

ER -